Zymergen Inc. (ZY) News
Filter ZY News Items
ZY News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest ZY News From Around the Web
Below are the latest news stories about ZYMERGEN INC that investors may wish to consider to help them evaluate ZY as an investment opportunity.
Ginkgo Bioworks Lifts Guidance After Mixed Q2 Results; Shares SurgeBy Yasin Ebrahim |
Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the FutureBeaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer. |
Is Ginkgo Bioworks Putting Its $1.5 Billion Cash Hoard to Good Use?The synthetic biology leader's healthy cash balance provides plenty of breathing room, but it won't last forever. |
Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock DealGinkgo Bioworks Holdings Inc (NYSE: DNA) agreed to acquire Zymergen Inc (NASDAQ: ZY) in an all-stock transaction. Zymergen stockholders will receive 0.9179 shares of Ginkgo's Class A common stock for each Zymergen share. The deal values Zymergen at approximately $300 million and would provide Zymergen shareholders about 5.25% pro forma ownership of Ginkgo. Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its foundry, incl |
Ginkgo to Acquire ZymergenToday, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen stockholders will receive a |
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery PlatformOctant doubles its initial investment in Zymergen’s Automation Technology to significantly increase the scale and throughput of its drug discovery platformEMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines. In May, Octant purchased five Reconfigurable Automation Carts, or RACs, to improve the throughput, efficie |
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing ApplicationsEMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to 3D4Makers for use in high performance 3D printing applications. 3D4Makers will convert the powder to filament, offering its first-ever polyimide filament to customers for use across a wide range of applications including aerospace, automotive, and transportation. Polyimide is a very high-strength polymer that is inh |
Celanese (CE) Soars 6%: Is Further Upside Left in the Stock?Celanese (CE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayGood morning, investors! |
Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery PlatformEMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with Octant for the sale of a modular automation system to scale Octant’s next-generation platform to develop breakthrough medicines. Zymergen’s complete automation solution includes modular hardware, modern web-based software, custom and turnkey workflows, and active monitoring and support. This technology will be incorporated into Octant’s existing |